EACR 2025: Congress: Innovative Cancer Science

Reveal the power of the 6-base genome. Introducing duet multiomics solution evoC. Distinguish 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC) together with all four canonical bases to measure multiple modes of biology from a single low-input DNA sample in a single experiment. Identify novel multimodal biomarkers to gain transformative insights into current and future states of disease.
16 June 2025
to 18 June 2025
Lisbon Congress Centre
, Lisbon

Visit biomodal at booth 

#50

About the event

The 2025 Annual Congress of the European Association for Cancer Research (EACR 2025) is a four day congress dedicated to basic, preclinical and translational cancer research across a wide breadth of topics. It will highlight the latest research and bring together the cancer research community to inspire innovation and build knowledge, connections and collaborations.

The European Association for Cancer Research (EACR) is a registered charity and global scientific community dedicated to the advancement of cancer research. We have been bringing cancer researchers together at our congress and conferences since 1968.

Presenting at the event

biomodal sponsored talk

Monday 16th June 12:15pm

Join biomodal for our sponsored talk on, further information to follow soon.

Find the venue

One sample. One workflow. One solution.

Here are the relevant biomodal resources for information. Find poster presentation information, case studies, interviews, and more.

Related resources

Attending from biomodal

Tom Charlesworth

Tom Charlesworth, PhD

Director of Market Strategy and Corporate Development
Rachel Aldridge

Rachel West

Regional Marketing Manager EMEA
Aziz Mustafa

Aziz Mustafa, PhD

Director of Sales and Business Development, Europe

Register now

EACR Jun 2025

Stay up to date

Explore recent biomodal news and the events that we’ll be attending in the near future.

Cambridge Epigenetix is now biomodal